RecruitingNot ApplicableNCT06699095

Home Rehabilitation As Continuity of Care in MS

"Tele-riabilitazione in Sclerosi Multipla: Continuità Terapeutica Domiciliare Dopo Trattamento Di Neuro-riabilitazione Intensiva, Studio Randomizzato Controllato Con Piattaforma Integrata Per La Riabilitazione Del Disequilibrio"


Sponsor

Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

Enrollment

20 participants

Start Date

Nov 6, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

RCT pilot study to evaluate adherence, satisfaction and feasibility in the use of a telemedicine station for balance rehabilitation in patients with multiple sclerosis. The platform is designed as a tool for maintenance rehabilitation in a home setting and not as an alternative to intensive treatment in hospital, and is therefore compared to maintenance treatment as usual (TAU) after intensive treatment.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria2

  • Expanded Disability Status Scale score between 3 and 6
  • Sensory Organisation Test Equitest values indicating balance impairment

Exclusion Criteria3

  • visual impairments
  • orthopedic impairments
  • inability to perform balance rehabilitation in stand up position

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETelerehabilitation

Patients will perform a 12 weeks rehabilitation program through telemedicine at home after intensive rehabilitation in hospital. Balance rehabilitation program will be scheduled on the patients' need and ability to be performed three times a week with high levels of satisfaction and safety at home under remote control of the physical therapist.


Locations(3)

IRCCS Istituto Auxologico Italiano

Milan, MI, Italy

Fondazione IRCCS Istituto Neurologico Carlo Besta

Milan, MI, Italy

IRCCS Santa Maria nascente - Fondazione Don Gnocchi

Milan, MI, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06699095


Related Trials